Intellectual Property

  • February 04, 2026

    SPEX Urges Fed. Circ. To Revert Slashed $1 IP Win To $553M

    SPEX Technologies Inc. is asking the Federal Circuit to reinstate the $553 million award it had won against Western Digital for patent infringement, after a California federal judge lowered it to a single dollar.

  • February 04, 2026

    GM Brings Design Patent Suits Over Alleged Car Part Copies

    General Motors has launched a trio of lawsuits in both Michigan and Illinois federal courts, accusing a host of companies of infringing the auto giant's design patents by selling copies of its car parts.

  • February 04, 2026

    Fed. Circ. Backs Infringement Immunity For NASA Contractor

    The Federal Circuit on Wednesday endorsed a California federal judge's decision that a NASA contractor doesn't have to face a patent infringement suit from a pair of California men, given that its allegedly infringing use was authorized by the federal government.

  • February 04, 2026

    Music Labels Win On Most Counts In Classic Rock Videos Suit

    Music labels suing a British filmmaker and his former company over a set of videos that made unauthorized use of songs by several classic rock artists were granted a win on a substantial portion of the case Wednesday by a Manhattan federal judge who found the videos did not contain enough legitimate commentary to be considered documentaries.

  • February 04, 2026

    Davis Polk Picks Up IP Ace From Debevoise & Plimpton

    Preeminent intellectual property attorney John "Jay" Neukom, who has a storied track record prevailing on behalf of major companies in high-profile legal battles across the country, has joined Davis Polk & Wardwell LLP in Northern California, after spending nearly four years with Debevoise & Plimpton LLC, according to an announcement made Monday.

  • February 04, 2026

    Teva Fights Class Cert. Bid In Effexor Antitrust Case

    Teva Pharmaceuticals urged a New Jersey federal judge Wednesday to reject a class certification bid by a group of direct buyers of the antidepressant drug Effexor XR and its generic versions, arguing that the proposed class failed to carry its burden showing that joinder is impracticable.

  • February 04, 2026

    IBM Seeks Texas Enforcement Of $24M UK Contract Ruling

    A British subsidiary of IBM asked a Texas federal court to enforce a $24.6 million English judgment against Houston-based software entrepreneur John Jay Moores, seeking to collect court-ordered litigation costs awarded after Moores was found to have breached IBM software licenses.

  • February 04, 2026

    USPTO's Squires Sees TMs As Key Tool Against AI Deepfakes

    U.S. Patent and Trademark Office Director John Squires pitched trademarks as one of the most practical tools for combating artificial intelligence deepfakes, saying during a Wednesday webinar that name, image and likeness rights are "where the puck is going," peppering his remarks with pop culture references and sports metaphors.

  • February 04, 2026

    Patent Settlement Blocks Fitness Tech ITC Case

    An Atlanta federal court said a U.S. fitness technology company can't go to the U.S. International Trade Commission to complain about an Australian rival's alleged patent-infringing bicycle training products because of a previous settlement agreement, ordering Wahoo to withdraw its ITC complaint.

  • February 04, 2026

    Whoop Nabs Block On Chinese Co.'s Health-Tracker Products

    A Massachusetts federal judge has blocked a Chinese company from selling in the U.S. its health-tracking products that were alleged by health band maker Whoop Inc. to be infringing its trade dress.

  • February 04, 2026

    Carnegie Mellon Avoids Alice Ax Of Patents In Calif. Suit

    A California federal judge has shot down a bid by an indirect Broadcom Inc. subsidiary to invalidate claims in a pair of Carnegie Mellon University patents the company has been accused of infringing, saying they passed muster under the U.S. Supreme Court's Alice test.

  • February 03, 2026

    XAI Fights Uphill To Keep Alive OpenAI IP Theft Suit

    Elon Musk's xAI urged a California federal judge Tuesday to change her tentative decision to toss its suit accusing OpenAI of poaching its workers to steal trade secrets, arguing that when considered together, the "whole gestalt" of xAI's allegations against individual employees is enough to state viable claims against OpenAI.

  • February 03, 2026

    Fed. Circ. Questions Bid To Undo Google, Microsoft PTAB Win

    A Federal Circuit panel appeared unpersuaded Tuesday by an inventor's arguments that the Patent Trial and Appeal Board should have ended reviews of computer-locating patents challenged by Google and Microsoft due to actions by LG in a related case, and that the board wrongly invalidated the patents.

  • February 03, 2026

    Martin Shkreli Countersues, Adds RZA To Wu-Tang Fight

    Martin Shkreli has filed counterclaims and added Wu-Tang Clan rappers and producers RZA and Cilvaringz as counterdefendants in litigation over the group's one-of-a-kind album he once owned, a move that comes just weeks after a New York federal judge rejected Shkreli's request to bring the Wu-Tang members into the dispute.

  • February 03, 2026

    Boston IP Firm Sees Malpractice Claims Revived By 1st Circ.

    The First Circuit has revived legal malpractice claims from a Colorado tech company that alleged it was betrayed when its lawyers at a Boston intellectual property law firm filed patents for another client, finding that a lower court's ruling that the claims were time-barred assumed the three-person company comprised exclusively of engineers had an understanding of tricky legal concepts.

  • February 03, 2026

    Squires And Stewart's Patent Office, By The Numbers

    The U.S. Patent and Trademark Office has seen sweeping changes under Director John Squires and Deputy Director Coke Morgan Stewart, ranging from pro-patent owner policies at the Patent Trial and Appeal Board to employment shake-ups that have prompted departures from the agency.

  • February 03, 2026

    TikTok, Cellspin Duel On Effects Of Sale In Patent Challenge

    TikTok has told the U.S. Patent and Trademark Office that the sale of its majority stake in its U.S. operations to a new joint venture should eliminate a patent owner's argument that the app's alleged relationship with the Chinese Communist Party should tank its patent challenges.

  • February 03, 2026

    Feds, Samsung Urge Justices To Reject PTAB Prior Art Case

    The federal government and Samsung have both urged the U.S. Supreme Court to reject a patent owner's challenge to the Federal Circuit's finding that the filing date of a patent dictates if it can be considered prior art.

  • February 03, 2026

    Tobacco Co. Says 'Time Bubble' Robbed It Of Fair TM Trial

    BBK Tobacco & Foods LLP is asking an Arizona federal court for a new trial on its trademark infringement claims against Central Coast Agriculture Inc., saying the court wrongly created a "time bubble" that excluded all evidence from May 2021 on.

  • February 03, 2026

    USPTO, With Squires' Signature, Seeks 'Board Of Peace' TMs

    The U.S. Patent and Trademark Office has filed a pair of applications for trademarks covering President Donald Trump's Board of Peace, with Director John Squires listed as the attorney pursuing the marks. 

  • February 03, 2026

    ATV Co. Accuses Rival Of Infringing Patents On Side-By-Sides

    Recreational vehicle manufacturer Polaris Inc. accused a rival of infringing its patents related to multi-occupant ATVs known as side-by-sides in two venues, filing a patent infringement suit in Minnesota federal court while also petitioning the U.S. International Trade Commission for an import ban on the products.

  • February 03, 2026

    Pharma Co. Stole Secrets For LSD Medical Trials, Suit Says

    A clinical trial services company is suing Definium Therapeutics Inc. in Delaware federal court, alleging that it stole trade secrets during Phase 2 trials of LSD treatments for psychiatric disorders, then passed those secrets on to a rival services company for Phase 3 trials.

  • February 03, 2026

    Fed. Circ. Backs Nearmap Win On 2 Out Of 3 PTAB Challenges

    The Federal Circuit on Tuesday stood by Nearmap's successful challenges at the Patent Trial and Appeal Board to a pair of patents covering a system for identifying attributes in a roof by using aerial imagery, but also refused to undo its unsuccessful challenge to another patent.

  • February 03, 2026

    4 Attys Sanctioned Over AI Hallucinations In Legal Brief

    A Kansas federal judge has issued sanctions against a group of lawyers representing a technology company in a patent dispute and has referred one attorney for disciplinary action over case citations hallucinated by ChatGPT appearing in a legal brief.

  • February 03, 2026

    Amway Looks To Sidestep Gut Drink Trademark Fight In NC

    Multi-level marketing giant Amway is seeking an early exit from a trademark infringement suit brought by a supplement maker in North Carolina, saying it has no ties to the Tar Heel state sufficient to be dragged into court there.

Expert Analysis

  • You're Out?: Rooftop Views Of Sports Games Raise IP Issues

    Author Photo

    A high-profile dispute between the Chicago Cubs and a rooftop business adjacent to Wrigley Field strikes at the intersection of sports, intellectual property and Chicago neighborhood tradition, highlighting novel questions that could significantly affect IP rights in the context of live events generally, say attorneys at Troutman Pepper.

  • 5 Key Steps To Prepare For Oral Arguments

    Author Photo

    Whether presenting oral arguments before the U.S. Supreme Court or a local county judge, effective preparation includes the same essential ingredients, from organizing arguments in blocks to maximizing the potential of mock exercises, says Allison Rocker at Baker McKenzie.

  • A Change In Big Pharma Response To FTC Delisting Warnings

    Author Photo

    While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent listings in the U.S. Food and Drug Administration's Orange Book had been de minimis through the end of last year, July data shows an increase in delistings, say Ratib Ali and Celia Lu at Competition Dynamics.

  • 9th Circ. Finding That NFTs Are Goods Will Change TM Law

    Author Photo

    The Ninth Circuit's recent ruling in Yuga Labs v. Ripps establishes that NFTs have real, commercial value under U.S. federal trademark law, a new legal precedent that may significantly influence intellectual property enforcement and marketplace policies regarding digital assets going forward, say attorneys at Wilson Elser.

  • Series

    Adapting To Private Practice: From Texas AUSA To BigLaw

    Author Photo

    As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.

  • Data Undermines USPTO's 'Settled Expectations' Doctrine

    Author Photo

    An analysis of inter partes review proceedings filed since 2012 appears to refute the U.S. Patent and Trademark Office's recent stance that patent owners develop a strong settled expectation that their patents will not be challenged after being in force for six years, say Jonathan DeFosse and Samuel Smith at Sheppard Mullin, and Kenzo Kasai at NGB Corp.

  • Advice For 1st-Gen Lawyers Entering The Legal Profession

    Author Photo

    Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.

  • Fed. Circ. In July: Instability In IPR Requirements

    Author Photo

    The Federal Circuit's decision in Shockwave v. Cardiovascular last month provided an important, albeit short-lived, clarification to the type of evidence that can be used in an inter partes review challenge, say attorneys at Knobbe Martens.

  • Structuring Noncompetes In License And Collaboration Deals

    Author Photo

    As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.

  • Series

    Coaching Cheerleading Makes Me A Better Lawyer

    Author Photo

    At first glance, cheerleading and litigation may seem like worlds apart, but both require precision, adaptability, leadership and the ability to stay composed under pressure — all of which have sharpened how I approach my work in the emotionally complex world of mass torts and personal injury, says Rashanda Bruce at Robins Kaplan.

  • 7 Ways To Fetch Patents In The World Of Working Animals

    Author Photo

    Though developers rarely file patents related to working animals, and animal training techniques are generally considered unpatentable, certain aspects of training and developing animals may be ripe for patent protection, say Matthew Avery at Baker Botts, Makenzi Galvan at Perkins Coie and Lute Yang at Orrick.

  • Ruling Puts 11th Circ. At Odds With Bankruptcy Courts

    Author Photo

    While an Eleventh Circuit majority recently found in BenShot v. 2 Monkey Trading and Lucky Shot USA that corporate debtors, like individuals, face certain exceptions to discharge under a nonconsensual Subchapter V plan, the ruling not only reverses the lower court, but opposes the holdings of many other bankruptcy courts, say attorneys at McDermott.

  • Series

    Law School's Missed Lessons: How To Make A Deal

    Author Photo

    Preparing lawyers for the nuances of a transactional practice is not a strong suit for most law schools, but, in practice, there are six principles that can help young M&A lawyers become seasoned, trusted deal advisers, says Chuck Morton at Venable.

  • A New IP Game Plan For College Football Players

    Author Photo

    For college stars navigating their first season under the newly implemented settlement in House v. NCAA and new NFL recruits, securing trademark rights isn't just a savvy business move — it's essential for building and protecting a personal brand that can outlast their playing days, says Ryan Loveless at CM Law.

  • From Clerkship To Law Firm: 5 Transition Tips For Associates

    Excerpt from Practical Guidance
    Author Photo

    Transitioning from a judicial clerkship to an associate position at a law firm may seem daunting, but by using knowledge gained while clerking, being mindful of key differences and taking advantage of professional development opportunities, these attorneys can flourish in private practice, say attorneys at Lowenstein Sandler.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.